Renaud. Dehareng

Renaud Dehareng currently serves as Chairman of the Board at a company in the CRO sector and as a Private Investor at CapVest and the Private Equity Club. Additionally, Renaud is a Private Investor at Whitestone Group and has held the position of Group Chief Executive Officer at Curium Pharma since March 2016. Renaud previously held the role of Chief Executive Officer at CALYX, and prior to that, served as CEO and COO at IBA Molecular. An early career was marked by leadership as Head of International Business Development at Wheels and as Senior Manager at Arthur Andersen Business Consulting. Renaud Dehareng holds an MBA in Business Administration from the University of Warwick - Warwick Business School.